Analysis of acetylcholinesterase inhibitors: bioanalysis, degradation and metabolism
- 10 December 2010
- journal article
- review article
- Published by Wiley in Biomedical Chromatography
- Vol. 25 (1-2) , 278-299
Abstract
Alzheimer's is a neurodegenerative disease. Its symptoms are attributed to a deficiency of cholinergic neurotransmission. The drugs of choice for the treatment of Alzheimer's disease are acetylcholinesterase (AChE) inhibitors. Starting in the 1980's from non‐specific AChE inhibitors, the first‐generation drugs such as physostigmine, a second generation of more selective and better tolerated products has been developed. Methods to detect and quantify these drugs and their metabolites in biological samples have been developed for analysis in plasma, blood, urine and cerebrospinal fluid. Diverse detection techniques have been used, such as ultraviolet, fluorescence, electrochemical and mass spectrometry. In this review, the methods applied to the analysis of these drugs and their metabolites in different biological matrices are reviewed and discussed. The stability of these drugs in biological matrices and under stress‐conditions is also included in the discussion. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 110 references indexed in Scilit:
- Production and on-line acetylcholinesterase bioactivity profiling of chemical and biological degradation products of tacrineJournal of Pharmaceutical and Biomedical Analysis, 2010
- Photohuperzine A—A new photoisomer of huperzine A: Structure elucidation, formation kinetics and activity assessmentJournal of Pharmaceutical and Biomedical Analysis, 2010
- The new approach in development of anti-Alzheimer's disease drugs via the cholinergic hypothesisChemico-Biological Interactions, 2008
- Quantification of huperzine A in Huperzia serrata by HPLC-UV and identification of the major constituents in its alkaloid extracts by HPLC-DAD-MS-MSJournal of Pharmaceutical and Biomedical Analysis, 2006
- Determination of donepezil hydrochloride in human and rat plasma, blood and brain microdialysates by HPLC with a short C30 columnJournal of Pharmaceutical and Biomedical Analysis, 2005
- Development of validated stability-indicating assay methods—critical reviewJournal of Pharmaceutical and Biomedical Analysis, 2002
- Mechanism of inhibition of cholinesterases by huperzine ABiochemical and Biophysical Research Communications, 1992
- A radioimmunoassay for physostigmine in biological fluids and tissuesJournal of Pharmaceutical and Biomedical Analysis, 1989
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Die Farbreaktionen des EserinsArchiv der Pharmazie, 1967